Skip to content
    Alphageneron
    • About
    • Team
      • Board
      • Management
      • Advisors
    • Technology
      • mHsp70
      • Enkastim
      • Ankastim
      • CAR NK
    • News
    • Contact
      You Are Here:
      Home Creative
      /
      Robert Brooks

      Author: Robert Brooks

      25Jun
      Alphageneron to Participate in the ROTH Virtual Healthcare Private Company Forum on June 28th, 2021
      By Robert Brooksin Press Releases

      Alphageneron to Participate in the ROTH Virtual Healthcare Private Company Forum on June 28th, 2021

      CAMBRIDGE, Mass., June 25, 2021 (GLOBE NEWSWIRE) — Alphageneron Pharmaceuticals, Inc. (“Alphageneron” or the “Company”), a privately-held clinical-stage biopharmaceutical company developing autologous and allogeneic Natural Killer (NK) cellular and antibody therapeutics announced…

      04Feb
      Alphageneron Pharmaceuticals Signed Exclusive License Agreement With Multimmune GmbH For Natural Killer Cell Platform Therapy Worldwide
      By Robert Brooksin Press Releases

      Alphageneron Pharmaceuticals Signed Exclusive License Agreement With Multimmune GmbH For Natural Killer Cell Platform Therapy Worldwide

      CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) — Alphageneron Pharmaceuticals, Inc., (Alphageneron) signed an Exclusive License Agreement with Multimmune GmbH, of Munich, Germany, (Multimmune) on October 1st, 2020, for its…

      • About
      • Team
      • Technology
      • News
      • Contact
      © 2022 Alphageneron. All Rights Reserved.

      Sign up

      Facebook Google Twitter
      or enter your registration credentials
      Already have an account?Log in
      Sign up

      Login

      Facebook Google Twitter
      or use your login data
      Don't have an account? Click here toSign up
      Remember me
      Log in